Blocking structural changes may restore the effectiveness of the cancer drug venetoclax, according to Rutgers Health ...

An international study conducted by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative ...

As Suleika Jaouad faces leukemia for the third time in 15 years, she is sharing her story with CURE.

Cancer is classified as the uncontrollable growth of mutated cells. There are different types of cancers that correlate to ...

Canonization of the Roman Catholic Saint Carlo shines a spotlight on the near cure of acute promyelocytic leukemia — a rare, ...

The Leukemia & Lymphoma Society, now Blood Cancer United®, and The US Oncology Network have established a collaboration to ...

Watch as Gabe Fholer rings the bell to celebrate being cancer-free. Doctors say a breakthrough drug helped make it happen.

Venetoclax mechanism of action is to inhibit BCL2 pathway, a protein that prevents apoptosis (programmed cell death) in cancer cells. BCL2 is a key factor in AML resistance, as it allows cancer cells ...

Bryn Ailinger had a rare mutation that made her leukemia less responsive to tradition treatment. But CAR T-Cell therapy ...